Nevro reports Q4 EPS ($1.41), consensus (75c)
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 04 2025
0mins
Financial Performance: Nevro reported Q4 revenue of $105.5 million, exceeding consensus estimates, with a strong balance sheet showing $292.5 million in cash and investments as of December 31, 2024.
Future Plans: CEO Kevin Thornal expressed optimism about the company's restructuring efforts and the upcoming partnership with Globus Medical to enhance their capabilities in addressing chronic pain.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
